GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Realcan Pharmaceutical Group Co Ltd (SZSE:002589) » Definitions » Forward Dividend Yield %

Realcan Pharmaceutical Group Co (SZSE:002589) Forward Dividend Yield % : 0.37% (As of Jul. 05, 2025)


View and export this data going back to 2011. Start your Free Trial

What is Realcan Pharmaceutical Group Co Forward Dividend Yield %?

As of today (2025-07-05), the Forward Annual Dividend Yield of Realcan Pharmaceutical Group Co is 0.37%.

As of today (2025-07-05), the Trailing Annual Dividend Yield of Realcan Pharmaceutical Group Co is 0.24%.

SZSE:002589's Forward Dividend Yield % is ranked worse than
96.97% of 66 companies
in the Medical Distribution industry
Industry Median: 2.74 vs SZSE:002589: 0.37

Realcan Pharmaceutical Group Co's Dividends per Share for the three months ended in Mar. 2025 was ¥0.00.

During the past 3 years, the average Dividends Per Share Growth Rate was 3.60% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Realcan Pharmaceutical Group Co was 69.40% per year. The lowest was -44.30% per year. And the median was 10.95% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Realcan Pharmaceutical Group Co's Forward Dividend Yield %

For the Medical Distribution subindustry, Realcan Pharmaceutical Group Co's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Realcan Pharmaceutical Group Co's Forward Dividend Yield % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Realcan Pharmaceutical Group Co's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Realcan Pharmaceutical Group Co's Forward Dividend Yield % falls into.


;
;

Realcan Pharmaceutical Group Co Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Realcan Pharmaceutical Group Co Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
CNY 0.0070002024-11-292024-11-282024-11-29Cash Dividendsemi-annuallyCNY:CNY 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Realcan Pharmaceutical Group Co's Forward Annual Dividend Yield (%) for Today is calculated as

Forward Annual Dividend Yield=Forward Full Year Dividend/Current Share Price
=0.014/2.99
=0.47 %

Current Share Price is ¥2.99.
Realcan Pharmaceutical Group Co's Dividends per Share for the forward twelve months is calculated as ¥0.007 * 2 = ¥0.014.

Realcan Pharmaceutical Group Co's Trailing Annual Dividend Yield (%) for Today is calculated as

Trailing Annual Dividend Yield=Most Recent Full Year Dividend/Current Share Price
=0.007/2.99
=0.23 %

Current Share Price is ¥2.99.
Realcan Pharmaceutical Group Co's Dividends per Share for the trailing twelve months (TTM) ended in Today is ¥0.007.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Realcan Pharmaceutical Group Co  (SZSE:002589) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Realcan Pharmaceutical Group Co Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Realcan Pharmaceutical Group Co's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Realcan Pharmaceutical Group Co Business Description

Traded in Other Exchanges
N/A
Address
No. 326, Airport Road, Zhifu District, Shandong Province, Yantai, CHN, 264004
Realcan Pharmaceutical Group Co Ltd is a Chinese company engaged in direct pharmaceuticals distribution services. The company's main business is divided into the Drug, vaccine, medical device circulation service; Medical industry third-party logistics; Medical information service; Medical logistics service; Chinese medicine plate; Hospital management sector; Medical industry research and development production sector; and Medical industry financial sector.
Executives
Zhang Ren Hua Directors, executives
Han Xu Director
Zhou Yun Directors, Directors, and Executives
Wu Di Executives
Su Li Chen Executives
Wu Li Yan Director
Tao Chun Fang Supervisors
Han Song Executives

Realcan Pharmaceutical Group Co Headlines

No Headlines